Walkersville, MD (PRWEB) September 16, 2010
Lonza will offer a live, customer-focused Webinar on the benefits and value of implementing MODA™--a paperless QC Micro solution--on Tuesday, September 28, 2010 at 11:00 AM ET (8:00 AM PT, 9:00 PM MT).
The presentation will feature Frank Bernard, Director of Information Technology (IT), User Services & Automation at XOMA Ltd., a proven leader in the discovery, development, and manufacture of therapeutic antibodies.
Webinar topics will include:
- XOMA's Previous Processes; Need for Automation and Integration with LIMS
- XOMA's New Automated QC Micro Program
- Why XOMA Selected the MODA™ Solution by Lonza
- MODA™ Solution Benefits and User Acceptance
- XOMA's Plans for the Future
To learn more and register, visit http://tmecom.com/lonza/webinars/092810/index.html
Paper-based processes still burden most QC Micro programs: paper scheduling, sharpie pen labeling of sample media, manual reconciliation, paper log book entry, and manual notification on deviations. These steps are labor-intensive, time consuming, and yield duplication of tasks and high error rates. XOMA's successful implementation of the MODA™ platform helped them achieve their goal to automate their QC process for improved Environmental Monitoring and compliance across their lab and manufacturing operations.
In May 2010, MODA became a Lonza company. What started as a company-wide initiative to eliminate waste, reduce lead and labor time, and improve overall compliance, inspired a robust informatics platform for the life sciences industry.
About MODA™ Solution
More science. Less paper.™ The MODA™ product strengthens Lonza's Rapid Testing Solutions platform by adding a complementary product offering for quality assurance (QA) and quality control (QC) organizations in the life science industry. The MODA™ solution offers automated data collection, on demand analytics and workflow visualization of regulated manufacturing processes, including environmental monitoring, utility testing, and product testing. The MODA™ mobile data acquisition platform eliminates inefficiencies and reduces error rates inherent with paper-based systems in regulated manufacturing operations. Further information can be found at http://www.lonza.com/moda
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers' needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2009, the company had sales of CHF 2.690 billion. Further information can be found at http://www.lonza.com.